Fig. 3

Attitudes toward choosing an approved fetal enzyme replacement therapy. Respondents were asked the question “If you or your partner were to become pregnant and the fetus were diagnosed with MPS, choose fetal enzyme replacement therapy?” A All respondents (n = 191), B Comparison of respondents from the United States (n = 115) and the United Kingdom (n = 35) (p = 0.8, Fisher’s exact test), C Variables with statistical significance on univariate and multivariable regression. MPS6 Mucopolysaccharidosis type 6, OR odds ratio, CI confidence interval, ERT enzyme replacement therapy